Mind Medicine’s (NASDAQ: MNMD) filed its preliminary proxy materials on Tuesday with the U.S. Securities and Exchange Commission (SEC) for its yet to be scheduled annual shareholders’ meeting, lining up the proverbial battle lines against an activist investor run by the company’s co-founder. In its proxy statement, MindMed laid out its nominees for the six-person company … Continue reading Proxy Fight Looms For MindMed Vs. Co-Founder